CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics Inc 's Tangible Leverage Ratio

ATRA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




ATRA Tangible Leverage Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Tangible Equity Change 11.15 % 64.08 % -10.96 % -14.19 % -20.99 %
Y / Y Total Liabilities Change 11.34 % 12.23 % 14.54 % 54.45 % 28.43 %
Tangible Leverage Ratio MRQ 0.15 0.12 0.18 0.18 0.15
Overall Ranking # # # # #
Seq. Tangible Equity Change -7.13 % 50.75 % -13.05 % -8.69 % 37.09 %
Seq. Total Liabilities Change 9.81 % 0.56 % -10.42 % 12.55 % 10.7 %



Tangible Leverage Ratio third quarter 2020 Comment
Due to net new borrowings of 9.81%, Tangible Leverage Ratio detoriated to 0.15, above company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2020, 40 other companies have achieved lower Tangible Leverage Ratio than Atara Biotherapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is ATRA Market Share?
Tangible Leverage Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 41
Healthcare Sector # 118
Overall Market # 236


Tangible Leverage Ratio Statistics
High Average Low
0.2 0.09 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics Inc 's Tangible Equity $ 354 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics Inc 's Total Liabilities $ 52 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Tangible Leverage RatioSep 30 2020 MRQ Total LiabilitiesSep 30 2020 MRQ Tangible Equity
Tracon Pharmaceuticals Inc   0.40 $ 6.166  Millions$ 15.486  Millions
Intellia Therapeutics Inc   0.39 $ 128.935  Millions$ 329.620  Millions
Beam Therapeutics Inc   0.39 $ 78.202  Millions$ 200.071  Millions
Eyenovia Inc   0.39 $ 7.197  Millions$ 18.650  Millions
Volitionrx Ltd  0.38 $ 7.103  Millions$ 18.663  Millions
Vericel Corporation  0.37 $ 42.874  Millions$ 114.630  Millions
Lineage Cell Therapeutics Inc   0.37 $ 11.824  Millions$ 32.345  Millions
Syndax Pharmaceuticals Inc   0.36 $ 47.332  Millions$ 131.977  Millions
Axcella Health Inc   0.35 $ 31.391  Millions$ 88.762  Millions
Zymeworks Inc   0.35 $ 139.365  Millions$ 396.313  Millions
Voyager Therapeutics Inc   0.35 $ 57.850  Millions$ 166.236  Millions
Homology Medicines Inc  0.34 $ 58.140  Millions$ 170.222  Millions
Surface Oncology Inc   0.34 $ 29.242  Millions$ 86.064  Millions
Fulgent Genetics Inc   0.32 $ 60.356  Millions$ 186.955  Millions
G1 Therapeutics Inc   0.31 $ 60.760  Millions$ 197.472  Millions
Orgenesis Inc   0.30 $ 24.092  Millions$ 79.004  Millions
Regenxbio Inc   0.30 $ 125.514  Millions$ 415.660  Millions
Atyr Pharma Inc  0.30 $ 9.475  Millions$ 31.998  Millions
Quanterix Corp  0.30 $ 55.064  Millions$ 186.085  Millions
Jounce Therapeutics Inc   0.29 $ 30.746  Millions$ 105.087  Millions
Azurrx Biopharma Inc   0.29 $ 2.657  Millions$ 9.085  Millions
Scpharmaceuticals Inc   0.29 $ 26.097  Millions$ 89.815  Millions
Cohbar Inc   0.29 $ 5.458  Millions$ 19.020  Millions
Bluebird Bio Inc   0.28 $ 422.463  Millions$ 1,498.781  Millions
Protagonist Therapeutics inc   0.28 $ 47.730  Millions$ 169.590  Millions
Eidos Therapeutics Inc   0.28 $ 34.358  Millions$ 122.856  Millions
Adaptimmune Therapeutics Plc  0.27 $ 102.816  Millions$ 374.236  Millions
Casi Pharmaceuticals Inc   0.27 $ 21.440  Millions$ 78.512  Millions
Cannabics Pharmaceuticals Inc   0.26 $ 0.455  Millions$ 1.765  Millions
Procyon Corp  0.25 $ 0.583  Millions$ 2.366  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DVA's Profile

Stock Price

DVA's Financials

Business Description

Fundamentals

Charts & Quotes

DVA's News

Suppliers

DVA's Competitors

Customers & Markets

Economic Indicators

DVA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071